Ado-trastuzumab emtansine Intravenous and Ergomar Sublingual Tablets
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Ergomar Sublingual Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: ergotamine
Brand name: Ergomar
Synonyms: Ergomar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Ergonovine
- Ado-trastuzumab emtansine Intravenous-Ergotamine
- Ado-trastuzumab emtansine Intravenous-Ergotamine and Caffeine
- Ado-trastuzumab emtansine Intravenous-Ergotamine and Caffeine Suppositories
- Ado-trastuzumab emtansine Intravenous-Ergotamine and Caffeine Tablets
- Ado-trastuzumab emtansine Intravenous-Ergotamine Tartrate
- Ergomar Sublingual Tablets-Adox Pak 2/100
- Ergomar Sublingual Tablets-Adoxa
- Ergomar Sublingual Tablets-Adoxa CK
- Ergomar Sublingual Tablets-Adoxa Pak
- Ergomar Sublingual Tablets-Adoxa Pak 1/100
- Ergomar Sublingual Tablets-Adoxa Pak 1/150